Status:
COMPLETED
Piloting a Naloxone Intervention in Philadelphia
Lead Sponsor:
Drexel University
Collaborating Sponsors:
Bar-Ilan University, Israel
Conditions:
Opioids; Harmful Use
Eligibility:
All Genders
18+ years
Brief Summary
The escalating opioid overdose epidemic is one of the most serious public health problems confronting the U.S. Death due to drug overdose is a significant and rising cause of mortality and morbidity i...
Detailed Description
The escalating opioid overdose epidemic is one of the most serious public health problems confronting the U.S. In 2014, a record 47,055 people died from a drug overdose in the U.S., which outnumbered ...
Eligibility Criteria
Inclusion
- 1\. Weekly misuse of heroin and/or rx opioid during past 30 days OR knows active, former, or deceased NMOU 2. Currently lives in zip codes 19122, 19125, 19133, 19134 3. Willingness to carry naloxone 4. Owns smartphone/data package 5. 18 years old or older 6. Speaks/reads English
Exclusion
- Younger than 18
- Does not speak/read English
Key Trial Info
Start Date :
October 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03305497
Start Date
October 23 2018
End Date
May 31 2021
Last Update
September 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kensington
Philadelphia, Pennsylvania, United States, 19134